Can 800 mg Daily Ibuprofen Cause Tinnitus?
Yes, ibuprofen 800 mg daily can cause tinnitus, though the risk is relatively modest and dose-dependent. This is a recognized central nervous system adverse effect of NSAIDs, particularly in older adults like this 60-year-old patient.
Evidence for NSAID-Induced Tinnitus
The mechanism is well-established. Tinnitus from NSAIDs is reversible and may indicate elevated medication blood levels 1. While this adverse effect is rare, it occurs more commonly in older persons 1. The 2009 guideline specifically identifies tinnitus as a recognized CNS side effect of NSAIDs, though it emphasizes this is uncommon.
Large-scale longitudinal data support this association. In a study of nearly 70,000 women followed for over 1 million person-years, frequent NSAID use was associated with significantly higher risk of developing persistent tinnitus 2. Specifically:
- Using NSAIDs 4-5 days/week: hazard ratio 1.17 (95% CI: 1.08-1.28)
- Using NSAIDs 6-7 days/week: hazard ratio 1.07 (95% CI: 1.00-1.16)
- Clear dose-response relationship (p-trend=0.001)
The risk increases with frequency of use, and at 800 mg daily (a moderate therapeutic dose), this patient falls into the higher-frequency use category.
The Wegovy (Semaglutide) Factor
Wegovy itself is independently associated with tinnitus, which complicates this clinical picture. Recent pharmacovigilance data show:
- Liraglutide (another GLP-1 RA) had significant signals for tinnitus 3
- In FDA adverse event database analysis, tinnitus represented 93 of 958 otologic adverse events (0.99%) with GLP-1 RAs 4
- A 2024 FAERS analysis identified tinnitus as a recognized adverse event with these medications 5
The combination of ibuprofen and semaglutide may create additive risk for tinnitus development, as both medications independently carry this potential adverse effect.
Clinical Implications
At age 60, this patient has multiple risk factors:
- Age >60 years (established risk factor for NSAID-induced CNS effects) 1
- Daily NSAID use (frequency-dependent risk) 2
- Concurrent GLP-1 RA therapy (independent tinnitus risk) 3, 4
Key Pitfalls to Avoid:
- Don't dismiss tinnitus as unrelated to medications in patients on multiple ototoxic agents
- Don't assume the dose is "too low" to cause effects—800 mg daily represents consistent moderate-dose exposure
- Don't overlook the reversible nature—discontinuation may resolve symptoms 1
Recommendation
Consider discontinuing or reducing the ibuprofen dose to determine if tinnitus improves, as NSAID-induced tinnitus is reversible 1. If anti-inflammatory therapy is essential, consider:
- Reducing frequency to <4 days/week (lower risk threshold) 2
- Switching to acetaminophen cautiously (though it also carries tinnitus risk at frequent use) 2
- Monitoring for resolution over 2-4 weeks after discontinuation
Monitor for other GLP-1 RA otologic effects including hearing changes, vertigo, or ear fullness, as these have been reported with semaglutide 3, 4. The tinnitus may persist if primarily driven by the Wegovy, but reducing cumulative ototoxic exposure is prudent.
Document baseline hearing status and consider audiology referral if tinnitus persists after NSAID discontinuation, as this would suggest the GLP-1 RA as the primary culprit requiring different management considerations.